These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7515671)

  • 41. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
    Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative evaluation of AgNOR in liver cells by high-resolution image cytometry.
    Vidal Bde C; Planding W; Mello ML; Schenck U
    Anal Cell Pathol; 1994 Jul; 7(1):27-41. PubMed ID: 7981134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of silver-stained nucleolar organizer regions is coupled to cell cycle in rat thymic cells.
    Carbajo S; Orfao A; Vicente-Villardón JL; Carbajo-Pérez E
    Cytometry; 1993; 14(1):46-52. PubMed ID: 8432202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interest of argyrophilic proteins nucleolar organizer regions (AgNOR) to estimate the reactivity of T cell clones against autologous malignant B-NHL cells.
    Wozniak ZM; Bonnefoix T; Zheng X; Seigneurin D; Sotto JJ
    Anal Cell Pathol; 1995 Sep; 9(2):123-33. PubMed ID: 7492516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silver-stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis.
    Contractor H; Rüschoff J; Hanisch T; Ulshöfer B; Neumann K; Schultze-Seemann W; Thomas C
    Urol Int; 1991; 46(1):9-14. PubMed ID: 1708924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines of AgNOR quantitation. Committee on AgNOR Quantitation within the European Society of Pathology.
    Aubele M; Biesterfeld S; Derenzini M; Hufnagl P; Martin H; Ofner D; Ploton D; Rüschoff J
    Zentralbl Pathol; 1994 Mar; 140(1):107-8. PubMed ID: 7515667
    [No Abstract]   [Full Text] [Related]  

  • 47. Morphometric investigation on nuclear and nucleolar arrangement and AgNOR content in the rat hippocampus under normal and ischemic conditions.
    Mennel HD; Müller I
    Exp Toxicol Pathol; 1994 Dec; 46(6):491-501. PubMed ID: 7703682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [AgNORs in cells of urothelial carcinoma of the bladder. A quantitative study using automatic microscopic image analysis].
    Martin H; Hufnagl P; Wenzelides K; Beil M
    Zentralbl Pathol; 1991; 137(6):505-9. PubMed ID: 1805929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AgNOR staining and quantification.
    Trerè D
    Micron; 2000 Apr; 31(2):127-31. PubMed ID: 10588058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential silver staining in lymphocytes and lymphoblastoid cell cultures.
    Martin-DeLeon PA; Muneses C; Picciano S; Mealey J; Dickerson R
    Cytobios; 1988; 55(221):113-23. PubMed ID: 2465871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequential demonstration of antigens and AgNORs in frozen and paraffin sections.
    Murray PG; Boldy DA; Crocker J; Ayres JG
    J Pathol; 1989 Oct; 159(2):169-72. PubMed ID: 2478688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AgNOR evaluation by image processing methods. Staining modifications and results in 126 invasive ductal breast carcinomas.
    Giménez-Mas JA; Gallego-Calvo P; Sanz-Moncasi P; Ríos-Mitchell J; Valero I; Sanz-Anquela M; Burriel J; Bavai A
    Anal Quant Cytol Histol; 1996 Feb; 18(1):9-18. PubMed ID: 8851103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How should we count AgNORS? Proposals for a standardized approach.
    Crocker J; Boldy DA; Egan MJ
    J Pathol; 1989 Jul; 158(3):185-8. PubMed ID: 2475599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate.
    Ahiskali R; Alican Y; Ekicioğlu G; Cevik I; Küllü S; Akdaş A
    Prostate; 1995 Feb; 26(2):105-10. PubMed ID: 7531845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
    Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
    Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Polyethylene glycol-thiosulfate (PEG-Th) staining--a modification of the AgNOR method].
    Löhr CV; Driemeier D; Teifke JP
    Zentralbl Pathol; 1995 Apr; 140(6):465-8. PubMed ID: 7538785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Significance of Two Dimensional AgNOR Evaluation in Local Advanced Rectal Cancer Treated with Chemoradiotherapy.
    Gundog M; Yildiz OG; Imamoglu N; Aslan D; Aytekin A; Soyuer I; Soyuer S
    Asian Pac J Cancer Prev; 2015; 16(18):8155-61. PubMed ID: 26745054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methods in pathology. The use of a colloidal silver (AgNOR) method in assessing bone marrow iron stores and sideroblasts.
    Nikicicz EP; Norback DH
    Mod Pathol; 1991 May; 4(3):363-7. PubMed ID: 2068063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AgNOR cut-point to distinguish mild and moderate epithelial dysplasia.
    Chattopadhyay A; Ray JG
    J Oral Pathol Med; 2008 Feb; 37(2):78-82. PubMed ID: 18197851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial silver staining patterns of human nucleolus organizer regions (NORs).
    Taylor EF; Martin-DeLeon PA
    Am J Hum Genet; 1981 Jan; 33(1):67-76. PubMed ID: 6162381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.